Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.36% on an annualized basis producing an average annual return of 29.01%. Currently, Novavax has a market capitalization of $2.42 billion.
Buying $100 In NVAX: If an ...
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.36% on an annualized basis producing an average annual return of 29.01%. Currently, Novavax has a market capitalization of $2.42 billion.
Buying $100 In NVAX: If an ...
Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...